Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
Akpek
E K
EK
Karadayi
K
K
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002387:Cataract Extraction; D009877:Endophthalmitis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D020911:Ketorolac Tromethamine / Q000627:therapeutic use*; D009883:Ophthalmic Solutions; D014677:Pharmaceutical Vehicles / Q000627:therapeutic use; D011183:Postoperative Complications; D016032:Randomized Controlled Trials as Topic
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009883:Ophthalmic Solutions; D014677:Pharmaceutical Vehicles; D020911:Ketorolac Tromethamine